Discretely assist companies and boards of directors conducting internal audits and investigations.
International Trade & National Security Law Firm
At Torres Trade Law, we work with U.S. and international clients - from multinationals and Fortune 500 companies to medium-sized businesses and startups - to successfully import and export goods, technology, and services. We regularly assist clients navigate regulatory challenges posed by U.S. and foreign trade policies, including China tariffs, Iran sanctions, and the export of defense-related goods and controlled or emerging technologies.
In addition, our lawyers have extensive experience assisting clients with a wide range of foreign investment matters, including the Committee on Foreign Investment in the United States (CFIUS) administering the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA).
Our lawyers regularly guide clients through myriad U.S. regulatory regimes and agencies that govern trade with the United States, including:
- U.S. Customs and Border Protection (CBP)
- The U.S. Department of Commerce Bureau of Industry and Security (BIS)
- The U.S. Department of State Directorate of Defense Trade Controls (DDTC)
- U.S. Department of the Treasury Office of Foreign Assets Control (OFAC)
- The Department of Defense Security Service (DSS)
- The Committee on Foreign Investment in the United States
To assist clients with challenges across the world, Torres Trade Law is a member of two widely recognized international associations: the International Lawyers Network, a global law firm network of more than 90 law firms in 67 countries; and Alliott Group, the world's 6th largest multidisciplinary alliance of accounting and law firms. These associations allow the firm to combine local expertise with a global reach to provide clients effective cross-border solutions.
To assist with risk advisory, complex investigations, and risk intelligence, our law firm's network also includes former intelligence officers and former senior leadership in national U.S. government security positions.
PRACTICE AREAS
.png "Top Advisors 2026")
.jpg "Chambers Ranked Global 2024")
.jpg "Chambers Ranked USA 2024")
Our Approach
Torres Trade Law is driven by the principle that our clients are best served by long-term relationships built on transparency, accountability, and cost-effectiveness. Our goal: to provide practical, real-world international trade advice based on an in-depth understanding of each client's strategic and business objectives coupled with comprehensive knowledge of the regulatory and competitive environments in which it does business.
We have extensive experience assisting companies in a variety of industries, including aerospace, defense contractors, commercial aviation, military electronics, chemicals and pharmaceuticals, medical equipment, food and beverage, data processing, machine tools, commercial electronics, satellite, unmanned vehicles, software and hi-tech, fashion and retail, private equity, and many others.
INSIGHTS
Torres Trade Trump Table
Date: 04/08/2026
For the latest Trump trade executive actions, please view the below Torres Trade Trump Table for important information. This table will be monitored and updated regularly. The last update occurred April 8, 2026.
Global Tariff Navigator
Date: 04/08/2026
Our Global Tariff Navigator delivers the latest U.S. tariff rates by country, updated often to reflect the ever changing trade policies - last refreshed April 8, 2026. Stay ahead of shifting trade winds!
After Sanctions Relaxation, New Opportunities in Venezuela But Risks Remain
By: Derrick Kyle, Senior Associate
Date: 04/08/2026
Since the U.S. military’s abrupt capture of Venezuelan President Nicolás Maduro on January 3, 2026, the Trump administration has authorized many activities involving Venezuela that were previously prohibited under U.S. sanctions. Specifically, the Department of the Treasury’s Office of Foreign Assets Control (OFAC) has issued numerous General Licenses (GLs) affecting the country’s energy and minerals sectors and allowing for greater participation by U.S. persons.
Trump Administration Spotlights Deceptive Made in America Claims
By: Olga Torres, Managing Member
Date: 04/08/2026
On March 13, 2026, the Trump administration issued an executive order (EO), "Ensuring Truthful Advertising of Products Claiming to Be Made in America," which seeks to increase enforcement related to the accuracy of products labeled “Made in America” or "Made in the USA." The EO reaffirms consumers’ right to accurate product information in the digital marketplace.
BIS’s 2026 Enforcement Agenda Takes Shape: Lessons Learned from Exyte, Applied Materials, and Teledyne
By: Camille Edwards, Associate
Date: 04/08/2026
The Bureau of Industry and Security (“BIS”) has opened 2026 with several significant administrative enforcement actions that underscore how aggressively the agency is policing export controls involving China, Entity List parties, semiconductor-related trade, and even highly technical compliance issues such as de minimis calculations and recordkeeping. Among the most notable matters announced so far this year are the Exyte Management GmbH, Applied Materials, and Teledyne FLIR settlements. Taken together, these cases show that BIS continues to focus not only on obvious diversion or evasion risks, but also on flawed legal interpretations, compliance-process failures, and gaps in post-license controls.
New Section 232 Tariff Measures on Steel, Aluminum, Copper, and Pharmaceutical Imports
By: Camille Edwards, Associate
Date: 04/08/2026
On April 2, 2026, the one-year anniversary of President Trump’s “Liberation Day” tariff announcement1, the administration published two new presidential actions related to tariffs under Section 232 of the Trade Expansion Act of 1962. The first of these actions is a Presidential Proclamation that re-shapes previously implemented Section 232 tariff measures on imports of steel, aluminum, and copper products (“the Metals Proclamation”). In addition to the Metals Proclamation, the President issued a separate Executive Order implementing a 100% tariff on imports of patented pharmaceutical products and ingredients.